• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM Back to Search Results
Model Number INSULIN
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/24/2019
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The customer collected negative mixed serum samples and performed dilution tests for troubleshooting purposes.The insulin results for these samples were approximately 4.3 uu/ml and were diluted 20, 40 and 80 times respectively with the following results: 194.6 uu/ml (calculated result 3892 uu/ml), 115.1 uu/ml (calculated result 4604 uu/ml) and 56.99 uu/ml (calculated result 4559.2 uu/ml).The customer concluded there were endogenous interfering substances in the samples resulting in non-specific binding of the reaction process affecting the insulin results.The investigation is ongoing.
 
Event Description
The initial reporter questioned a high result not corresponding to the clinical picture for 1 patient sample tested for elecsys insulin (insulin) on a cobas 6000 e 601 module.The insulin result was > 1000 uu/ml.This result was reported outside of the laboratory.The patient's c-peptide result was normal at 1.02 nmol/l.The customer also checked other results from the patient: free-kap was 40.200 mg/l and free lam was 1090.000 mg/l.These results are used in the clinical diagnosis and monitoring of multiple myeloma.The customer suspects an interference in the patient sample affecting the insulin results based on the high free-kap and free lam results.The e601 module serial number was (b)(4).
 
Manufacturer Narrative
Based on the calibration and qc data provided, a general reagent issue is excluded.The alarm trace from (b)(6)2019 shows several messages related to sample quality.There was no sample available for further investigation.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS INSULIN
Type of Device
IMMUNOREACTIVE INSULIN TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9197098
MDR Text Key217924198
Report Number1823260-2019-03746
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
PMA/PMN Number
K001104
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/16/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Model NumberINSULIN
Device Catalogue Number12017547122
Device Lot Number315724
Was Device Available for Evaluation? Yes
Date Manufacturer Received09/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age64 YR
-
-